1 Introduction (Page No. – 16)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders
2 Research Methodology (Page No. – 20)
2.1 Research Data
2.2 Research Methodology Steps
2.2.1 Secondary Data
2.2.1.1 Secondary Sources
2.2.2 Primary Data
2.2.2.1 Key Insights From Primary Sources
2.2.3 Market Size Estimation Methodology
2.2.4 Revenue Mapping-Based Market Estimation
2.3 Market Data Estimation and Triangulation
2.4 Assumptions for the Study
3 Executive Summary (Page No. – 29)
4 Premium Insights (Page No. – 32)
4.1 Market Overview
4.2 Geographic Analysis: European Cardiac Mappingmarket, By Indication & Country (2019)
4.3 Market Share, By Type, 2019 vs. 2024
4.4 Market Share, By Indication, 2019 vs. 2024
4.5 Geographic Outlook: Market
5 Market Overview (Page No. – 36)
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 New Entrants in the Market
5.2.1.2 Growing Investments, Funds, and Grants
5.2.1.3 Increasing Incidence of Target Diseases
5.2.1.4 Growth in the Geriatric Population
5.2.2 Restraints
5.2.2.1 Unfavorable Healthcare Reforms in the US
5.2.2.2 Lack of Skilled and Experienced Electrophysiologists
5.2.3 Opportunities
5.2.3.1 Emerging Markets
5.2.3.2 Technological Advancements
5.2.4 Challenges
5.2.4.1 Unfavorable Regulatory Scenario
5.2.4.2 Alternative Technologies
6 Cardiac Mapping Market, By Type (Page No. – 43)
6.1 Introduction
6.2 Contact Cardiac Mapping Systems
6.2.1 Electroanatomical Mapping Systems
6.2.1.1 Electroanatomical Mapping Systems Account for the Largest Share of the Contact Mapping Systems Market
6.2.2 Basket Catheter Mapping Systems
6.2.2.1 Basket Catheter Mapping Systems Provide Simultaneous, Multiple, Stable Recordings for Most Endocardial Surfaces—A Key Factor Driving Market Growth
6.2.3 Traditional Endocardial Catheter Mapping Systems
6.2.3.1 Exposure to Ionizing Radiation Due to the Need for Fluoroscopy Guidance is A Key Disadvantage of Traditional Endocardial Catheter Mapping Systems
6.3 Non-Contact Cardiac Mapping Systems
6.3.1 Non-Contact Mapping is Applicable in Cases Where the Arrhythmia Cannot Be Tolerated Or in Cases Where Clinical Arrhythmia is Not Reproducible During the Electrophysiology Study
7 Cardiac Mapping Market, By Indication (Page No. – 55)
7.1 Introduction
7.2 Atrial Fibrillation
7.2.1 Growing Number of Cases of Atrial Fibrillation and the Subsequent Increase in the Number of Ablation Procedures to Drive Market Growth
7.3 Atrial Flutter
7.3.1 High Success Rate of Radiofrequency Catheter Ablation for the Treatment of Atrial Flutter is A Major Factor Contributing to the Growth of This Market
7.4 Atrioventricular Nodal Reentry Tachycardia (Avnrt)
7.4.1 Growing Number of Avnrt Cases Across the Globe is Supporting the Growth of This Segment
7.5 Other Arrhythmias
8 Cardiac Mapping Market, By Region (Page No. – 65)
8.1 Introduction
8.2 North America
8.2.1 US
8.2.1.1 High Burden of Cvds to Drive the Demand for Cardiac Mapping in the US
8.2.2 Canada
8.2.2.1 Growing Focus of Government Organizations on Providing Research Funding to Support Market Growth in Canada
8.3 Europe
8.3.1 Germany
8.3.1.1 Favorable Healthcare Expenditure and Growing Use of Crt Devices to Drive Market Growth
8.3.2 UK
8.3.2.1 Rising Geriatric Population to Support Market Growth
8.3.3 France
8.3.3.1 Increasing Incidence of Heart Failure to Support Market Growth
8.3.4 Italy
8.3.4.1 Increasing Incidence of Cvd to Drive the Adoption of Cardiac Mapping Systems
8.3.5 Spain
8.3.5.1 Increasing Cardiac Ablation Procedures to Drive the Market in Spain
8.3.6 Rest of Europe
8.4 Asia Pacific
8.4.1 Japan
8.4.1.1 Favourable Reimbursement Scenario to Support Market Growth
8.4.2 China
8.4.2.1 Growing Geriatric Population to Drive the Market for Cardiac Mapping Systems
8.4.3 India
8.4.3.1 Increasing Government Initiatives Towards Healthcare are Supporting the Growth of the Market in India
8.4.4 Rest of Asia Pacific
8.5 Rest of the World
9 Competitive Landscape (Page No. – 95)
9.1 Introduction
9.2 Market Ranking Analysis
9.3 Competitive Leadership Mapping (Overall Market)
9.3.1 Visionary Leaders
9.3.2 Innovators
9.3.3 Emerging Companies
9.3.4 Dynamic Differentiators
9.4 Competitive Scenario
9.4.1 Product Launches & Approvals
9.4.2 Partnerships, Agreements, and Collaborations
9.4.3 Acquisitions
10 Company Profile (Page No. – 103)
(Business Overview, Products Offered, Recent Developments, Competitive Analysis)*
10.1 Biosense Webster, Inc. (A Johnson & Johnson Company)
10.2 Abbott Laboratories
10.3 Medtronic Plc
10.4 Boston Scientific Corporation
10.5 Microport Scientific Corporation
10.6 EP Solutions Sa
10.7 Acutus Medical
10.8 Koninklijke Philips N.V.
10.9 Lepu Medical
10.1 Biotronik
10.11 Angiodynamics
10.12 Biosig Technologies, Inc.
10.13 APN Health, LLC
10.14 Coremap
10.15 Kardium, Inc.
10.16 Catheter Precision, Inc.
10.17 Epmap-System
*Business Overview, Products Offered, Recent Developments, Competitive Analysis Might Not Be Captured in Case of Unlisted Companies.
11 Appendix (Page No. – 129)
11.1 Discussion Guide
11.2 Knowledge Store: Marketsandmarkets’ Subscription Portal
11.3 Available Customizations
11.4 Related Reports
11.5 Author Details
